Dartmouth Logo

Dartmouth Logo

Thursday, October 24, 2013

Career Catalyst Research (CCR) Grants: Clinical Research

Sponsor
Komen for the Cure, Susan G.
Amount
Upper  $450,000USD
Applicants/PIs may request funding of up to $150,000 per year (combined direct and indirect costs) for up to three years.
Requirements
Academic Institution
New Faculty/New Investigator
Nonprofit
Citizenship or Residency
Unrestricted
Activity location
Unrestricted
Abstract
The grants are intended to foster promising breast cancer clinician-scientists who are in the early stages of their faculty careers by providing support for "protected time" for clinical research career development under the guidance of a mentor committee. It is expected that awardees will launch independent clinical research careers and successfully compete for subsequent clinicalresearch project funding in breast cancer following the successful completion of a CCR Grant. Grants provide support to clinician-scientists for hypothesis-driven clinical research projects that have significant potential to advance the understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move society toward the goal of a world without breast cancer. Komen defines clinical research as hypothesis driven, patient-orientedresearch for which an investigator directly interacts with human subjects/patients, in conjunction with laboratory-based research, as appropriate. This includes studies such as therapeutic interventions or clinical trials. Appropriate research projects include, but are not limited to, the following areas: - Novel approaches that enhance understanding of the breast cancer disease process; - Etiology; - Prevention; - Detection; - Biomarkers of risk, disease burden, and/or treatment response or resistance; - Novel therapeutics; - Lifestyle interventions with the potential to affect disease outcomes (e.g., incidence and/or mortality); - Research seeking to understand the biologic, behavioral, and social causes of disparities in breast cancer outcomes across population groups or identify, validate and test health services and public health interventions that address the causes of disparities in care and outcomes; and - Studies focusing on quality of life or survivorship issues. 

No comments:

Post a Comment